The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection

Monoclonal antibodies are widely used both in infants and in adults for several indications. Humanized monoclonal antibodies (palivizumab) have been used for many years for the prevention of respiratory syncytial virus infection in pediatric populations (preterm infants, infants with chronic lung di...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanari, Marcello, Vandini, Silvia, Arcuri, Santo, Galletti, Silvia, Faldella, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693113/
https://www.ncbi.nlm.nih.gov/pubmed/23840240
http://dx.doi.org/10.1155/2013/359683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693113/
https://www.ncbi.nlm.nih.gov/pubmed/23840240
http://dx.doi.org/10.1155/2013/359683

Ejemplares similares